3 jobs found in Fargo, ND

This is a high-impact, individual contributor sales role introducing a truly differentiated capital technology into an aesthetics market that has looked the same for decades. You will own a meaningful territory, work directly with top plastic surgeons and dermatologists, and help scale a reengineered, clinically validated platform at a pivotal growth inflection point. It is a rare chance to be early, influential, and well compensated while helping redefine how non-surgical skin tightening is done. WHY YOU'LL LOVE IT: • A chance to sell a disruptive product. • Joining a high-growth, startup culture. • Industry veteran leadership and great culture. THE IDEAL CANDIDATE: • Has experience selling aesthetic capital equipment. • Is comfortable with travel. • Is a true hunter and enjoys winning new business.

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at  www.axsome.com  and follow us on  LinkedIn  and  X . About This Role Axsome Therapeutics is...

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at  www.axsome.com  and follow us on  LinkedIn  and  X . About This Role Axsome Therapeutics is...